Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Jost

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|August 17, 2015
A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemiaMartina Crysandt, Michael Kramer, Gerhard Ehninger, et al.
Journal of Hematology & Oncology|September 3, 2016
A three-gene expression-based risk score can refine the European LeukemiaNet AML classificationStefan Wilop, Wen-Chien Chou, Edgar Jost, et al.
Annals of Hematology|July 5, 2017
Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemiaMónica S Ventura Ferreira, Martina Crysandt, Patrick Ziegler, et al.
Genomics|December 12, 2003
A gene expressed exclusively in acute B lymphoblastic leukemiasAlexandra Vialle-Castellano, Sandra Laduron, Etienne De Plaen, et al.
Life Science Alliance|December 25, 2018
Variants of <i>DNMT3A</i> cause transcript-specific DNA methylation patterns and affect hematopoiesisTanja Božić, Joana Frobel, Annamarija Raic, et al.
Digital Health|March 14, 2024
Application of wearables for remote monitoring of oncology patients: A scoping reviewKatharina Cloß, Marlo Verket, Dirk Müller-Wieland, et al.
Annals of Hematology|February 9, 2024
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysisKailun David Zhang, Edgar Jost, Jens Panse, et al.
Transplantation and Cellular Therapy|August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell TransplantationNico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
Cancer Research|December 18, 2003
Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cellsMehmet K Tur, Michael Huhn, Theo Thepen, et al.
British Journal of Haematology|October 20, 2017
Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteinsGerrit Gresch, Lea Schenke, Radoslav Mladenov, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|August 17, 2015
A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemiaMartina Crysandt, Michael Kramer, Gerhard Ehninger, et al.
Journal of Hematology & Oncology|September 3, 2016
A three-gene expression-based risk score can refine the European LeukemiaNet AML classificationStefan Wilop, Wen-Chien Chou, Edgar Jost, et al.
Annals of Hematology|July 5, 2017
Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemiaMónica S Ventura Ferreira, Martina Crysandt, Patrick Ziegler, et al.
Genomics|December 12, 2003
A gene expressed exclusively in acute B lymphoblastic leukemiasAlexandra Vialle-Castellano, Sandra Laduron, Etienne De Plaen, et al.
Life Science Alliance|December 25, 2018
Variants of <i>DNMT3A</i> cause transcript-specific DNA methylation patterns and affect hematopoiesisTanja Božić, Joana Frobel, Annamarija Raic, et al.
Digital Health|March 14, 2024
Application of wearables for remote monitoring of oncology patients: A scoping reviewKatharina Cloß, Marlo Verket, Dirk Müller-Wieland, et al.
Annals of Hematology|February 9, 2024
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysisKailun David Zhang, Edgar Jost, Jens Panse, et al.
Transplantation and Cellular Therapy|August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell TransplantationNico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
Cancer Research|December 18, 2003
Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cellsMehmet K Tur, Michael Huhn, Theo Thepen, et al.
British Journal of Haematology|October 20, 2017
Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteinsGerrit Gresch, Lea Schenke, Radoslav Mladenov, et al.
Pageof 11